Domestic Terrorism and Hate Crimes Prevention Act of 2021

Domestic Terrorism Prevention Act (HR 350 and S 963)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Health Care Supply Chain - Advocated for the importance of hospital group purchasing organizations, and highlighted role in supporting supply chain resiliency to secure essential, authentic medical supplies for hospitals throughout the course of the COVID-19 pandemic. Supported adoption of effort to reduce greenhouse gas emissions and environmentally preferred sourcing for health care supplies. Engaged to support policies to limit shortages of prescription drugs. Advocated for greater transparency in the health care supply chain for drugs and medical devices. Build Back Better Act (H.R. 5376) - Supported policies to encourage health care coverage and close the Medicaid coverage gap. Public Health Emergency - Advocated for HHS to further extend the declared Public Health Emergency. Telehealth - Supported efforts to make telehealth flexibilities offered during COVID-19 Public Health Emergency permanent. Supported CONNECT for Health Act (S. 1512/H.R. 2903) and encouraged reimbursement parity for certain telehealth services and support for audio-only telehealth services. Health Care Workforce - Urged passage of the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act (H.R. 708; S. 168); The Health Care Workforce Resilience Act (S. 1024/H.R. 2255); The Dr. Lorna Breen Health Care Provider Protection Act (S.610/H.R. 1667); The Resident Physician Shortage Reduction Act (S.834/H.R. 2256). The Opioid Workforce Act (S. 1438/H.R. 3441). Urged administration to examine practices of health care staffing agencies. Supported passage of the Travel Nursing Agency Transparency Study Act (S. 4352). Supported passage of the Safety from Violence for Healthcare Employees Act (H.R. 7961). Prepare for and Respond to Existing Viruses, Emerging New Threats, and (PREVENT) Pandemics Act (S. 3799) - monitored Senate Committee adoption of PREVENT Pandemics Act. Supported inclusion of provisions to improve supply chain transparency and extend shelf life of prescription drugs. Supported passage of the Integrity, Notification, Fairness in Online Retail Marketplaces (INFORM) Consumers Act (S. 963/H.R. 5502). 340B Drug Pricing Program - Urged HHS to enforce guidance that would allow 340B Covered Entities to utilize contract pharmacies. Food and Drug Administration User Fees (S. 4348, H.R.7667) - Urged inclusion of provisions in FDA user fee legislation to provide greater authorities for the FDA to promote supply chain transparency, clarifying language related to the Unapproved Drugs Initiative, the PASTUER Act (S.2076) and the PATCH Act (H.R. 7084). Social Determinants of Health and Health Equity - Shared insights and offered suggestions to CMS regarding health equity measurement, indices and data collection. Supported the Social Determinants Accelerator Act (H.R. 2503; S. 3039); The LINC to Address Social Needs Act (S. 509). Antimicrobial resistance (S. 2076) - Supported passage of the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act. Supported passage of Opioid Treatment Access Act (S. 3629/H.R. 6279). Supported passage of Drug Shortage Shelf Life Extension Act (S. 3493).

H.R. 7666 - The Restoring Hope for Mental Health and Well Being Act of 2022 - Issues related to improving the treatment of mental health issues and substance use disorder in the nation. Executive Orders related to fixing the Family Glitch in ACA coverage, increasing and enhancing policies to support diversity and easing medical debt for Americans. Senate Reconciliation Efforts - Support for many health care provisions including continuation and expansion of ARPA health policies (see below), policies to close the coverage gap in states that have not yet expanded Medicaid and policies focused on bolstering home and community based services and workforce. PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, incentives to expand Medicaid for those in states that have not expanded through the ACA, post-partum women and people returning to society, and other related issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. H.R. 959 - The Momnibus Act - Issues related to achieving better outcomes and equity for mothers to be and new mothers in America. The ReEntry Act - support for providing Medicaid services for incarcerated individuals 30 days before leaving prison. Issues related to easing the burden of medical debt.

Client expense: Not reported · Firm income: $20,000

Build Back Better Act (H.R. 5376) - Supported policies to encourage health care coverage and close the Medicaid coverage gap. Urged additional pandemic financial support for hospitals. Advocated for investments for hospitals and health care providers, including physical structure improvements, workforce and graduate medical education support. Public Health Emergency - Advocated for HHS to further extend the declared Public Health Emergency. Telehealth -Supported provisions in the Consolidated Appropriations Act, 2022 (H.R. 2471) to temporarily extend certain flexibilities after the end of the public health emergency. Supported passage of the CONNECT for Health Act (S. 1512/H.R. 2903) to make telehealth flexibilities permanent. Encouraged reimbursement parity for certain telehealth services and support for audio-only telehealth services. Health Care Workforce - Urged passage of the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act (H.R. 708; S. 168); The Health Care Workforce Resilience Act (S. 1024/H.R. 2255); The Dr. Lorna Breen Health Care Provider Protection Act (S.610/H.R. 1667); The Resident Physician Shortage Reduction Act (S.834/H.R. 2256). The Opioid Workforce Act (S. 1438/H.R. 3441). Urged administration to examine practices of health care staffing agencies. Health Care Supply Chain - Advocated for the importance of hospital group purchasing organizations, and highlighted role in supporting supply chain resiliency to secure essential, authentic medical supplies for hospitals throughout the course of the COVID-19 pandemic. Engaged to support policies to limit shortages of prescription drugs. Advocated for greater transparency in the health care supply chain for drugs and medical devices. Prepare for and Respond to Existing Viruses, Emerging New Threats, and (PREVENT) Pandemics Act (S. 3799) - monitored introduction of PREVENT Pandemics Act. Supported inclusion of provisions to improve supply chain transparency and extend shelf life of prescription drugs. Supported passage of the Integrity, Notification, Fairness in Online Retail Marketplaces (INFORM) Consumers Act (S. 963/H.R. 5502). Provider Relief Fund - Urged HHS and Congress to offer greater flexibility and extend deadlines for hospitals to utilize PRF funding and provide clear guidance on reporting expectations. Supported Provider Relief Deadline Extension Act (S. 2493) and Provider Relief Fund Improvement Act (H.R. 5963/S.3611). Drug Pricing - Reviewed options to further support modifications to the unapproved drugs initiative that would prevent or limit price increases for older, unapproved drugs. Supported changes to the 340B program and urged HHS to enforce guidance that would allow 340B Covered Entities to utilize contract pharmacies. Advocated for HHS to offer additional 340B Drug Pricing Program eligibility flexibility for hospitals that have had patient mix changed during the COVID-19 public health emergency (S. 773). Supported inclusion of provisions in Consolidated Appropriations Act, 2022 (H.R. 2471) that would extend eligibility for covered entities that may have lost eligibility during the public health emergency. Medical Device User Fee Amendments - Urged greater authorities for the FDA to promote supply chain transparency. Generic Drug User Fee Amendments - Supported rapid adoption of generic drug user fee amendments, and urged inclusion of clarifying language related to the Unapproved Drugs Initiative and the PASTUER Act (S.2076). Social Determinants of Health and Health Equity - Shared insights and offered suggestions to CMS regarding health equity measurement, indices and data collection. Supported the Social Determinants Accelerator Act (H.R. 2503; S. 3039); The LINC to Address Social Needs Act (S. 509). Antimicrobial resistance (S. 2076) - Supported passage of the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act. Supported passage of Opioid Treatment Access Act (S. 3629/H.R. 6279). Supported passage of Drug Shortage Shelf Life Extension Act (S. 3493).

Domestic Terrorism Prevention Act (HR 350 and S 963)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2471 - Consolidated Appropriations Act for FY 2022 - Issues related to funding Consumer Assistance Programs, continuing pandemic-related health care programs for families, and related issues. Executive Orders related to fixing the Family Glitch in ACA coverage, increasing and enhancing policies to support diversity and easing medical debt for Americans. H.R. 5376 - Build Back Better Act - Support for many health care provisions including continuation and expansion of ARPA health policies (see below), policies to close the coverage gap in states that have not yet expanded Medicaid and policies focused on bolstering home and community based services and workforce. PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, incentives to expand Medicaid for those in states that have not expanded through the ACA, post-partum women and people returning to society, and other related issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. H.R. 959 - The Momnibus Act - Issues related to achieving better outcomes and equity for mothers to be and new mothers in America. The ReEntry Act - support for providing Medicaid services for incarcerated individuals 30 days before leaving prison. Issues related to easing the burden of medical debt. Issues related to supporting consumer assistance programs (CAPs) through the Labor/HHS Appropriations process. Issues related to ensuring equitable health care coverage for low income individuals in all 50 states.

Client expense: Not reported · Firm income: $20,000

We supported S. 3029/HR 2154 protecting Americans from Dangerous Algorithms; S963/HR 350 domestic terrorism prevention and hate crimes prevention act

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Domestic Terrorism Prevention Act (HR 350 and S 963)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Domestic Terrorism Prevention Act (HR 350 and S 963)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Build Back Better Act (H.R. 5376) - Supported policies to encourage health care coverage and close the Medicaid coverage gap. Urged additional pandemic financial support for hospitals. Advocated for investments for hospitals and health care providers, including physical structure improvements, workforce and graduate medical education support. Infrastructure Investment and Jobs Act (H.R. 3684) - Supported inclusion of funding to support broadband deployment needed for greater access to telehealth services. Opposed using further extension of Medicare sequestration or repurposing unused provider relief funding as offsets for bipartisan infrastructure package. Telehealth - Supported passage of the CONNECT for Health Act (S. 1512/H.R. 2903) to make telehealth flexibilities permanent. Encouraged reimbursement parity for certain telehealth services and support for audio-only telehealth services. Health Care Workforce - Urged passage of the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act (H.R. 708; S. 168); The Health Care Workforce Resilience Act (S. 1024/H.R. 2255); The Dr. Lorna Breen Health Care Provider Protection Act (S.610/H.R. 1667); The Resident Physician Shortage Reduction Act (S.834/H.R. 2256). Urged administration to examine practices of health care staffing agencies. Surprise Bills - Urged changes to the Surprise Billing Interim Final Rule Part 2 to modify its reliance on a "Qualifying Payment Amount" in an Independent Dispute Resolution process. Hospital Group Purchasing Organizations - Advocated for the importance of hospital group purchasing organizations, and highlighted role in supporting supply chain resiliency to secure essential, authentic medical supplies for hospitals throughout the course of the COVID-19 pandemic. Engaged to support policies to limit shortages of prescription drugs. Engaged with U.S. DOT Port Envoy related to shipping delays for key medical products. Advocated for greater transparency in the health care supply chain for drugs and medical devices. Supported passage of the Integrity, Notification, Fairness in Online Retail Marketplaces (INFORM) Consumers Act (S. 963/H.R. 5502). Provider Relief Fund - Urged HHS and Congress to offer greater flexibility and extend deadlines for hospitals to utilize PRF funding and provide clear guidance on reporting expectations. Supported Provider Relief Deadline Extension Act (S. 2493) and Provider Relief Fund Improvement Act (H.R. 5963). Drug Pricing - Monitored drug pricing legislation (H.R. 3, H.R. 19, H.R. 5376) with support for policies that improve market competition and makes improvements to support hospital and patient access to needed medications. Reviewed options to further support modifications to the unapproved drugs initiative that would prevent or limit price increases for older, unapproved drugs. Monitored for potential changes to the 340B program and supported HHS to enforce guidance that would allow 340B Covered Entities to utilize contract pharmacies. Advocated for HHS to offer additional 340B Drug Pricing Program eligibility flexibility for hospitals that have had patient mix changed during the COVID-19 public health emergency (S. 773). Social Determinants of Health - Engaged to offer support for policies to improve social determinants of health. Offered feedback on legislation and activity from the CMS Innovation Center to improve access and reduce health care disparities. Supported the Social Determinants Accelerator Act (H.R. 2503; S. 3039); The LINC to Address Social Needs Act (S. 509). CURES 2.0 (H.R. 6000) - Monitored the introduction of CURES 2.0 Health Care Equity - Offered feedback on legislation to improve access to care and reduce health care disparities. Rural MOMS Act (H.R. 769); Black Maternal Health Momnibus Act (H.R. 959). Antimicrobial resistance (S. 2076) - Supported passage of the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act.

H.R. 5376 - Build Back Better Act - Support for many health care provisions including continuation and expansion of ARPA health policies (see below), policies to close the coverage gap in states that have not yet expanded Medicaid and policies focused on bolstering home and community based services and workforce. PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, incentives to expand Medicaid for those in states that have not expanded through the ACA, post-partum women and people returning to society, and other related issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. H.R. 959 - The Momnibus Act - Issues related to achieving better outcomes and equity for mothers to be and new mothers in America. The ReEntry Act - support for providing Medicaid services for incarcerated individuals 30 days before leaving prison. Issues related to easing the burden of medical debt. Issues related to supporting consumer assistance programs (CAPs) through the Labor/HHS Appropriations process. Issues related to ensuring equitable health care coverage for low income individuals in all 50 states.

Client expense: Not reported · Firm income: $20,000

We supported HR 2154 to deal with social media platforms use of algorithms; S 963/HR 350 for domestic terrorism prevention act dealing with the rise in anti-Semitic terror activity.

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Build Back Better Act (H.R. 5376) - Supported policies to encourage health care coverage and close Medicaid coverage gap. Urged additional pandemic financial support for hospitals. Advocated for support for investments for hospitals and health care providers, including physical structure improvements, workforce and graduate medical education support. Raised opposition to using further extension of Medicare sequestration or repurposing unused provider relief funding as offsets for bipartisan infrastructure package. Telehealth - Supported passage of the CONNECT for Health Act (S. 1512/H.R. 2903) to make telehealth flexibilities permanent. Encouraged reimbursement parity for certain telehealth services and support for audio-only telehealth services. Health Care Workforce - Urged passage of the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act (H.R. 708; S. 168); The Health Care Workforce Resilience Act (S. 1024/H.R. 2255); The Dr. Lorna Breen Health Care Provider Protection Act (S.610/H.R. 1667); The Resident Physician Shortage Reduction Act (S.834/H.R. 2256) Hospital Group Purchasing Organizations - Advocated for the importance of hospital GPOs, and highlighted role in supporting supply chain resiliency to secure essential, authentic medical supplies for hospitals throughout the course of the COVID-19 pandemic. Advocated for greater transparency in the health care supply chain for drugs and medical devices and greater transparency into the decision-making of the Strategic National Stockpile. Supported passage of the Integrity, Notification, Fairness in Online Retail Marketplaces (INFORM) Consumers Act (S. 963/H.R. 5502). Provider Relief Fund - Urged HHS and Congress to offer greater flexibility and extend deadlines for hospitals to utilize PRF funding and provide clear guidance on reporting expectations. Supported Provider Relief Deadline Extension Act (S. 2493) Drug Pricing - Monitored drug pricing legislation (H.R. 3, H.R. 19, H.R. 5376) with support for policies that improve market competition and provides improvements to support hospital and patient access to needed medications. Unapproved Drugs Initiative - Engaged with HHS and the FDA to support modifications to the unapproved drugs initiative that would prevent or limit unintended price increases for older unapproved products. 340B Drug Pricing Program - Urged HHS to enforce guidance that would allow 340B Covered Entities to utilize contract pharmacies. Advocated for HHS to offer additional 340B Drug Pricing Program eligibility flexibility for hospitals that have had patient mix changed during the COVID-19 public health emergency. Social Determinants of Health - Engaged to offer support for policies to improve social determinants of health. Social Determinants of Health Accelerator Act (H.R. 2503); The LINC to Address Social Needs Act (S. 509) Health Care Equity - Offered feedback on legislation to improve access to care and reduce health care disparities. Rurual MOMS Act (H.R. 769); Black Maternal Health Momnibus Act (H.R. 959). Stark Law and Anti-kickback Statute - Encouraged Congress to continue evaluating Stark and Anti-kickback statutes to better enable care coordination in value-based alternative payment models. Antimicrobial resistance (S. 2076) - Supported passage of the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act.

Domestic Terrorism Prevention Act (HR 350 and S 963)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Build Back Better Act - Support for many health care provisions including continuation and expansion of ARPA health policies (see below), policies to close the coverage gap in states that have not yet expanded Medicaid and policies focused on bolstering home and community based services and workforce. PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, incentives to expand Medicaid for those in states that have not expanded through the ACA, post-partum women and people returning to society, and other related issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. H.R. 959 - The Momnibus Act - Issues related to achieving better outcomes and equity for mothers to be and new mothers in America. The ReEntry Act - support for providing Medicaid services for incarcerated individuals 30 days before leaving prison. Issues related to easing the burden of medical debt. Issues related to supporting consumer assistance programs (CAPs) through the Labor/HHS Appropriations process. Issues related to ensuring equitable health care coverage for low income individuals in all 50 states.

Client expense: Not reported · Firm income: $20,000

PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, the need for a more robust pipeline for antibiotics to protect the nation, a more coherent HIT system to ensure robust public data and other related public health issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. S. 2076 - The Pioneering Antimicrobial Subscriptions to End Surging Resistance Act ( PASTEUR Act) - Issues related to improving the antibiotic pipeline to address antimicrobial resistance. Issues related to ensuring clear information regarding the safety of supplements. Issues related to dealing with antimicrobial resistance among the US population.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, the need for a more robust pipeline for antibiotics to protect the nation, a more coherent HIT system to ensure robust public data and other related public health issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. S. 2076 - The Pioneering Antimicrobial Subscriptions to End Surging Resistance Act ( PASTEUR Act) - Issues related to improving the antibiotic pipeline to address antimicrobial resistance. Issues related to enhanced patient matching systems. Issues related to ensuring clear information regarding the safety of supplements. HIT issues related to including Unique Device Identifiers in the Medicare Claims Forms.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

We supported HR 2154 to deal with social media platforms' use of algorithms; S 963/HR 350 for domestic terrorism prevention act dealing with the rise in anti-Semitic terror activity. Until it was enacted, we also supported the No Hate Act, which since has been signed into law.

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Hospital Group Purchasing Organizations - Advocated for the importance of hospital GPOs, and highlighted role in supporting supply chain resiliency to secure essential, authentic medical supplies for hospitals throughout the course of the COVID-19 pandemic. Advocated for greater transparency in the health care supply chain for drugs and medical devices and greater transparency into the decision-making of the Strategic National Stockpile. Supported passage of the Integrity, Notification, Fairness in Online Retail Marketplaces (INFORM) Consumers Act (S. 963). American Jobs Plan and American Families Plan Infrastructure Proposals - Monitored infrastructure proposals and advocated for support for investments in infrastructure for hospitals and health care providers, including physical structure improvements, workforce and graduate medical education support, efforts to prevent antimicrobial resistance and telehealth investments. Provider Relief Fund - Urged HHS and Congress to offer greater flexibility and extend deadlines for hospitals to utilize PRF funding and provide clear guidance on reporting expectations. Health Care Workforce - Urged passage of the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act (H.R. 708; S. 168). Drug Pricing - Monitored introductions of drug pricing legislation (H.R. 3, H.R. 19) and urged improvements to support hospital and patient access to needed medications. Unapproved Drugs Initiative - Engaged with HHS and the FDA to support modifications to the unapproved drugs initiative that would prevent or limit unintended price increases for older unapproved products. 340B Drug Pricing Program - Urged HHS to enforce guidance that would allow 340B Covered Entities to utilize contract pharmacies. Advocated for HHS to offer additional 340B Drug Pricing Program eligibility flexibility for hospitals that have had patient mix changed during the COVID-19 public health emergency. Stark Law and Anti-kickback Statute - Encouraged Congress to continue evaluating Stark and Anti-kickback statutes to better enable care coordination in value-based alternative payment models. Antimicrobial resistance (S. 2076) - Supported passage of the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act.

PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, incentives to expand Medicaid for those in states that have not expanded through the ACA, post-partum women and people returning to society, and other related issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. H.R. 959 - The Momnibus Act - Issues related to achieving better outcomes and equity for mothers to be and new mothers in America. Issues related to easing the burden of medical debt. Issues related to supporting consumer assistance programs (CAPs) through the Labor/HHS Appropriations process. Issues related to ensuring equitable health care coverage for low income individuals in all 50 states.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, the need for a more robust pipeline for antibiotics to protect the nation, a more coherent HIT system to ensure robust public data and other related public health issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. S. 2076 - The Pioneering Antimicrobial Subscriptions to End Surging Resistance Act ( PASTEUR Act) - Issues related to improving the antibiotic pipeline to address antimicrobial resistance. Issues related to enhanced patient matching systems. Issues related to ensuring clear information regarding the safety of supplements. HIT issues related to including Unique Device Identifiers in the Medicare Claims Forms.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, the need for a more robust pipeline for antibiotics to protect the nation, a more coherent HIT system to ensure robust public data and other related public health issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. S. 2076 - The Pioneering Antimicrobial Subscriptions to End Surging Resistance Act ( PASTEUR Act) - Issues related to improving the antibiotic pipeline to address antimicrobial resistance. Issues related to ensuring clear information regarding the safety of supplements. Issues related to dealing with antimicrobial resistance among the US population.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Support for Domestic Terrorism Prevention Act, H.R. 350/S. 963 Support for Commission on Domestic Terrorism Act, H.R. 1178 Support for Resolution condemning Proud Boys involvement in anti-government violence, H.Res. 115 Support for confirmation of Alejandro Mayorkas as Secretary of Homeland Security

Client expense: $50,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, State, Dept of (DOS), White House Office

PL 177-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, incentives to expand Medicaid for those in states that have not expanded through the ACA, post-partum women and people returning to society, and other related issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. Issues related to easing the burden of medical debt. Issues related to supporting consumer assistance programs (CAPs)

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

PL 177-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, the need for a more robust pipeline for antibiotics to protect the nation, a more coherent HIT system to ensure robust public data and other related public health issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. Issues related to ensuring clear information regarding the safety of supplements. Issues related to dealing with antimicrobial resistance among the US population.

Client expense: Not reported · Firm income: $60,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

PL 177-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, the need for a more robust pipeline for antibiotics to protect the nation, a more coherent HIT system to ensure robust public data and other related public health issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. Issues related to enhanced patient matching systems. Issues related to ensuring clear information regarding the safety of supplements. Issues related to dealing with antimicrobial resistance among the US population. HIT issues related to including Unique Device Identifiers in the Medicare Claims Forms.

Client expense: Not reported · Firm income: $60,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)